VNDA: Vanda Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 236.48
Enterprise Value ($M) 100.66
Book Value ($M) 544.91
Book Value / Share 9.47
Price / Book 0.43
NCAV ($M) 329.42
NCAV / Share 5.73
Price / NCAV 0.72

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.00

Liquidity (mrq)
Quick Ratio 4.92
Current Ratio 4.94

Balance Sheet (mrq) ($M)
Current Assets 432.95
Assets 648.44
Liabilities 103.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 192.64
Operating Income -13.95
Net Income 2.51
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 12.80
Cash from Investing -12.06
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Renaissance Technologies Llc 6.40 27.40
02-13 13G/A Vanguard Group Inc 6.01 -13.43
02-09 13G/A Dimensional Fund Advisors Lp 3.40 -31.04
01-23 13G/A BlackRock Inc. 14.50 23.48
01-22 13G/A State Street Corp 2.13 -67.06

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-07-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 147,930 1,170,206 12.64
2024-03-27 86,712 716,244 12.11
2024-03-26 50,644 604,360 8.38
2024-03-25 61,905 593,607 10.43

(click for more detail)

Similar Companies
VAXX – Vaxxinity, Inc. VCEL – Vericel Corporation
VERA – Vera Therapeutics, Inc. VRCA – Verrica Pharmaceuticals Inc.
WVE – Wave Life Sciences Ltd.


Financial data and stock pages provided by
Fintel.io